2 results
Approved WMOCompleted
To study whether hyqvia is as effective, safe and tolerable (or more tolerable) as IVIg.
Approved WMORecruiting
Primary Objectives:• To assess the efficacy (progression-free survival [PFS]) of DCC-2618 by independent radiologic review in patients with advanced gastrointestinal stromal tumors (GIST) who have previously received first-line therapy with…